AI-Powered Multi-Omics Integration for Exploring Disease-Associated Molecular Networks and Therapeutic Intervention Pathways

Authors

  • Cailin McEnaney Department of Computer Science, University of Alabama at Birmingham, Birmingham, AL, USA. Author
  • Kyra Phillipsen Department of Electrical Engineering and Computer Science, University of Kansas, Lawrence, KS, USA. Author

Keywords:

multi-omics integration; disease molecular networks; graph neural networks; pathway intervention; Bayesian uncertainty; network medicine

Abstract

Disease-associated molecular networks are shaped by interactions across genomic, transcriptomic, proteomic, epigenomic, and metabolomic layers, yet most integrative analyses still reduce multi-omics evidence to static gene lists or single-modality predictive scores. This limitation constrains both mechanistic interpretation and the identification of therapeutic intervention pathways, because a disease module, a target, and a combination of targets can be statistically associated with a phenotype without forming a coherent, modifiable network. The manuscript develops an analytical framework for AI-powered multi-omics integration that links latent-variable fusion to graph-based network inference and pathway-level intervention scoring. The proposed framework represents each sample through modality-specific likelihoods with missingness indicators, learns a shared latent state, and couples this state to a modality-weighted message-passing network built from prior interactions and data-derived edges. Disease association is expressed as a posterior over graphs and modules, while therapeutic hypotheses are ranked through pathway perturbation scores and a constrained combination objective that penalizes network dispersion, toxicity, and cost. A Bayesian uncertainty layer distinguishes confident network predictions from those that are primarily prior-driven, and sensitivity analysis is specified for graph structure, modality weighting, and missing-data mechanisms. The contribution is methodological: it provides a coherent way to connect multi-omics evidence, network topology, and intervention reasoning while preserving the distinction between predictive association and causal mechanism. The framework offers a technically defensible basis for prioritizing disease modules and combinatorial therapeutic hypotheses for subsequent experimental validation.

References

1. Hasin, Y., Seldin, M., & Lusis, A. J. (2017). Multi-omics approaches to disease. Genome Biology, 18, 83. https://doi.org/10.1186/s13059-017-1215-1

2. Karczewski, K. J., & Snyder, M. P. (2018). Integrative omics for health and disease. Nature Reviews Genetics, 19(5), 299–310. https://doi.org/10.1038/nrg.2018.8

3. Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011). Network medicine: A network-based approach to human disease. Nature Reviews Genetics, 12(1), 56–68. https://doi.org/10.1038/nrg2918

4. Menche, J., Sharma, A., Kitsak, M., Ghiassian, S. D., Vidal, M., Loscalzo, J., & Barabási, A.-L. (2015). Disease networks. Uncovering disease-disease relationships through the incomplete interactome. Science, 347(6224), 1257601. https://doi.org/10.1126/science.1257601

5. Zitnik, M., Nguyen, F., Wang, B., Leskovec, J., Goldenberg, A., & Hoffman, M. M. (2019). Machine learning for integrating data in biology and medicine: Principles, practice, and opportunities. Information Fusion, 50, 71–91. https://doi.org/10.1016/j.inffus.2018.09.012

6. Camacho, D. M., Collins, K. M., Powers, R. K., Costello, J. C., & Collins, J. J. (2018). Next-generation machine learning for biological networks. Cell, 173(7), 1581–1592. https://doi.org/10.1016/j.cell.2018.05.015

7. Argelaguet, R., Velten, B., Arnol, D., Dietrich, S., Zenz, T., Marioni, J. C., Stegle, O. (2018). Multi-Omics Factor Analysis—a framework for unsupervised integration of multi-omics data sets. Molecular Systems Biology, 14(6), e8124. https://doi.org/10.15252/msb.20178124

8. Wang, B., Mezlini, A. M., Demir, F., Fiume, M., Tu, Z., Brudno, M., Haibe-Kains, B., & Goldenberg, A. (2014). Similarity network fusion for aggregating data types on a genomic scale. Nature Methods, 11(3), 333–337. https://doi.org/10.1038/nmeth.2810

9. HerbSyner_Finder: a network community-based model for identifying synergistic combinations from herbal medicines and complex systems. Targetome. 2026;2(2):0-0. doi: 10.48130/targetome-0026-001

10. Ideker, T., Ozier, O., Schwikowski, B., & Siegel, A. F. (2002). Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics, 18(Suppl. 1), S233–S240. https://doi.org/10.1093/bioinformatics/18.suppl_1.S233

11. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., & Mesirov, J. P. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences, 102(43), 15545–15550. https://doi.org/10.1073/pnas.0506580102

12. Wang, K., Li, M., & Hakonarson, H. (2010). Analysing biological pathways in genome-wide association studies. Nature Reviews Genetics, 11(12), 843–854. https://doi.org/10.1038/nrg2884

13. Veličković, P., Cucurull, G., Casanova, A., Romero, A., Liò, P., & Bengio, Y. (2018). Graph attention networks. International Conference on Learning Representations. https://arxiv.org/abs/1710.10903

14. Kipf, T. N., & Welling, M. (2017). Semi-supervised classification with graph convolutional networks. International Conference on Learning Representations. https://arxiv.org/abs/1609.02907

15. Zitnik, M., Agrawal, M., & Leskovec, J. (2018). Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics, 34(13), i457–i466. https://doi.org/10.1093/bioinformatics/bty294

16. Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., Reich, M., Hieronymus, H., Wei, G., Armstrong, S. A., Haggarty, S. J., Clemons, P. A., Wei, R., Carr, S. A., Lander, E. S., & Golub, T. R. (2006). The Connectivity Map: Using gene-expression signatures to connect small molecules, genes, and disease. Science, 313(5795), 1929–1935. https://doi.org/10.1126/science.1132939

17. Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., Lahr, D. L., Hirschman, J. E., Liu, Z., Donahue, M., Julian, B., Khan, M., Wadden, D., Smith, I. C., Lam, D., ... Golub, T. R. (2017). A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell, 171(6), 1437–1452.e17. https://doi.org/10.1016/j.cell.2017.10.049

18. Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H., Cokelaer, T., Greninger, P., van Dyk, E., Chang, H., de Silva, H., Heyn, H., Deng, X., Egan, R. K., Liu, Q., ... McDermott, U. (2016). A landscape of pharmacogenomic interactions in cancer. Cell, 166(3), 740–754. https://doi.org/10.1016/j.cell.2016.06.017

19. Yuan, Y., & Bar-Joseph, Z. (2019). Deep learning for inferring gene relationships from single-cell expression data. Proceedings of the National Academy of Sciences, 116(52), 27151–27158. https://doi.org/10.1073/pnas.1915536116

20. Zhou, J., Theesfeld, C. L., Yao, K., Chen, K. M., Wong, A. K., & Troyanskaya, O. G. (2018). Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk. Nature Genetics, 50(8), 1171–1179. https://doi.org/10.1038/s41588-018-0160-6

Downloads

Published

2026-11-04